NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
04/16/2026
Back to search
Official data from USPTO
RXMED
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
45
Latest update
05/05/2026
Trademark type
Combined
Nice classes
35
Filing date
02/01/1993
Registration date
08/08/1995
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/16/2026
Last transaction
05/05/2026
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
05/28/1993
First use in commerce
05/28/1993
Drawing code
3
Owner type
03
Owner location
Louisville, KY, US
Examiner
HERMAN, RUSS
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
RXMED, INC.
GERIMED, INC.
Institute for Healthcare Cost Containment, Inc.
Representatives
Cynthia L. Stewart FBT Gibbons
Technical classification
Nice Classes
Class 35
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
group purchasing service for retail pharmacies
Publications
History of USPTO decisions and trademark events.
45 publications found
RNL3
REGISTERED AND RENEWED (THIRD RENEWAL - 10 YRS)
04/16/2026
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
04/16/2026
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
04/16/2026
E89R
TEAS SECTION 8 & 9 RECEIVED
02/06/2026
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
08/08/2024
NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
09/08/2015
RNL2
REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
09/08/2015
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
09/08/2015
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
09/08/2015
E89R
TEAS SECTION 8 & 9 RECEIVED
08/10/2015
MDSC
NOTICE OF DESIGN SEARCH CODE MAILED
12/23/2008
CFIT
CASE FILE IN TICRS
07/02/2007
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
12/10/2005
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
12/10/2005
PLGL
ASSIGNED TO PARALEGAL
12/01/2005
89AF
REGISTERED - COMBINED SECTION 8 (10-YR) & SEC. 9 FILED
07/19/2005
E89R
TEAS SECTION 8 & 9 RECEIVED
07/19/2005
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
03/26/2001
815F
REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED
11/02/2000
R.PR
REGISTERED-PRINCIPAL REGISTER
08/08/1995
PUBO
PUBLISHED FOR OPPOSITION
05/16/1995
NPUB
NOTICE OF PUBLICATION
04/14/1995
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/23/1994
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
12/23/1994
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/14/1994
IUAA
USE AMENDMENT ACCEPTED
09/14/1994
AUPC
AMENDMENT TO USE PROCESSING COMPLETE
08/30/1994
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
08/24/1994
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/17/1994
IURF
IU INFORMAL RESPONSE RECEIVED
07/18/1994
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/07/1994
IUFF
USE AFFIDAVIT FAILED FORMALITIES
06/17/1994
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
05/04/1994
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/26/1994
IUAF
USE AMENDMENT FILED
04/25/1994
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
04/19/1994
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/07/1994
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/09/1994
CNFR
FINAL REFUSAL MAILED
02/02/1994
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/06/1993
CNRT
NON-FINAL ACTION MAILED
10/28/1993
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/12/1993
CNRT
NON-FINAL ACTION MAILED
04/29/1993
DOCK
ASSIGNED TO EXAMINER
04/19/1993
Continuous trademark protection
Get notified about every new filing that threatens RXMED or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.